Johnson & Johnson
JNJ
#23
Rank
NZ$1.059 T
Marketcap
NZ$439.75
Share price
0.88%
Change (1 day)
52.35%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): NZ$15.18

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$14.82. In 2025 the company made an earnings per share (EPS) of NZ$18.89 an increase over its 2024 EPS that were of NZ$11.35.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$15.18-19.64%
2025NZ$18.8966.46%
2024NZ$11.35-53.6%
2023NZ$24.46111.16%
2022NZ$11.58-13.84%
2021NZ$13.4541.81%
2020NZ$9.48-18.92%
2019NZ$11.6921.2%
2018NZ$9.651125.3%
2017NZ$0.79-92.23%
2016NZ$10.137.37%
2015NZ$9.44-4.16%
2014NZ$9.8418.1%
2013NZ$8.3424.88%
2012NZ$6.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$11.91-19.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.22-85.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.12-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.34-57.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$47.88 223.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.34-70.70%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$12.59-15.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$14.81-0.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.06-59.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.59-55.51%๐Ÿ‡ฌ๐Ÿ‡ง UK